Inventory for COVID-19 Diagnostic Research & Development

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

The availability of reliable, rapid diagnostics is key to reopening our economies. Canada has an opportunity to take a leadership role in accelerating the development of these tests through a coordinated Canadian response. The goal is to support researchers to build networks and find collaborators/industry partners to advance their ideas to clinical trial and mass production. To that end, Dr. Mona Nemer and the Office of the Chief Science Advisor (OCSA) is creating an inventory of R&D activities for COVID-19 diagnostics in Canadian academic institutions. Your voluntary, non-confidential disclosure of your R&D project will help the OCSA support critical diagnostics activities and early identification of gaps.

Name (First Last)

Institution *

Contact email

Who has your permission to see this information other than the Office of the Chief Science Advisor? *

Other federal departments and agencies

OK to share within CanCOVID

Other researchers who have filled in this form

Other:

Required

What does your assay detect? *

virus (antigens and/or nucleic acid)

antibodies (serological)

Other:

Required

What samples can be tested using your new diagnostic method? *

nasal

oropharangeal swabs

saliva

venous blood

blood spot/pinprick

urine

stool

Other:

Required

What is the detection method (no acronyms please)? Examples: nucleic acid amplification, enzyme-linked immunoassay, matrix-assisted laser desorption/ionization *

What is the proposed test environment? *

centralized laboratory

point-of-care (performed by professional)

point-of-care (performed by non-professional)

Other:

Required

What advantage(s) does your test offer over existing testing methods? *

reduced testing time

improved performance characteristics

portability

ease-of-use

reduced reagent requirements

Other:

Required

Provide a short, non-confidential description of your assay. *

Provide a short description of where you are in the development of the assay. Examples: assay development, assay validation, prototype construction, pre-clinical or clinical evaluation. *

Please check the boxes of anything you would like help with and the timescale for that assistance. *

less than 4 weeks

1 to 6 months

more than 6 months

does not apply

Accessing specific reagents or controls

Accessing clinical specimens

Designing and prototyping

Finding an industrial partner

Scaling up (large-scale manufacturing)

Regulatory approval

Are you willing to be contacted to discuss opportunities? *

Yes

Please share any further information that might be useful to understand the nature of your activity.

Submit

Clear form

Never submit passwords through Google Forms.

This form was created inside of PANet @ The Western University. Report Abuse

Forms